Joel Lewis is the President, Chief Executive Officer, and Director of Galectin Therapeutics, a clinical-stage biopharmaceutical company focused on therapies.
Joel Lewis is the President, Chief Executive Officer, and Director of Galectin Therapeutics, a clinical-stage biopharmaceutical company focused on therapies for fibrotic disease and cancer. He was appointed Chief Executive Officer in 2020 and leads the company's development of galectin-3-targeted therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library